Cancer Trials in Salt Lake City, United States
Conditions / Cancer / Salt Lake City, United States
Research into Cancer spans multiple therapeutic approaches and trial phases.
76 total trials for this combination
Showing top 10 of 76 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05510908 | Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC | COMPLETED | — |
| NCT01345019 | Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma | COMPLETED | PHASE3 |
| NCT00105937 | OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients | COMPLETED | PHASE3 |
| NCT04464226 | Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer | ACTIVE_NOT_RECRUITING | — |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | RECRUITING | — |
| NCT05103358 | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. | COMPLETED | PHASE2 |
| NCT03678883 | 9-ING-41 in Patients with Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04274933 | A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy | TERMINATED | PHASE1 |
| NCT03899155 | Pan Tumor Rollover Study | RECRUITING | PHASE2 |